134 related articles for article (PubMed ID: 36456172)
41. CDX-2 Expression in Primary Lung Adenocarcinoma.
Cowan ML; Li QK; Illei PB
Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):16-9. PubMed ID: 26469326
[TBL] [Abstract][Full Text] [Related]
42. A mutation spectrum that includes GNAS, KRAS and TP53 may be shared by mucinous neoplasms of the appendix.
Hara K; Saito T; Hayashi T; Yimit A; Takahashi M; Mitani K; Takahashi M; Yao T
Pathol Res Pract; 2015 Sep; 211(9):657-64. PubMed ID: 26160192
[TBL] [Abstract][Full Text] [Related]
43. GATA6-positive lung adenocarcinomas are associated with invasive mucinous adenocarcinoma morphology, hepatocyte nuclear factor 4α expression, and KRAS mutations.
Nakajima N; Yoshizawa A; Nakajima T; Hirata M; Furuhata A; Sumiyoshi S; Rokutan-Kurata M; Sonobe M; Menju T; Miyamoto E; Chen-Yoshikawa TF; Date H; Haga H
Histopathology; 2018 Jul; 73(1):38-48. PubMed ID: 29469192
[TBL] [Abstract][Full Text] [Related]
44. A case of invasive mucinous adenocarcinoma of the lung showing stepwise progression at the primary site.
Kawai H; Sugano M; Nakano N; Muratani M; Sakashita S; Goto Y; Noguchi M
Lung Cancer; 2019 Oct; 136():94-97. PubMed ID: 31472337
[TBL] [Abstract][Full Text] [Related]
45. Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study.
Paliogiannis P; Colombino M; Sini MC; Manca A; Casula M; Palomba G; Pisano M; Doneddu V; Zinellu A; Santeufemia D; ; Sotgiu G; Cossu A; Palmieri G
BMC Pulm Med; 2022 Jan; 22(1):32. PubMed ID: 35012520
[TBL] [Abstract][Full Text] [Related]
46. Pulmonary adenocarcinoma with mucin production modulates phenotype according to common genetic traits: a reappraisal of mucinous adenocarcinoma and colloid adenocarcinoma.
Sonzogni A; Bianchi F; Fabbri A; Cossa M; Rossi G; Cavazza A; Tamborini E; Perrone F; Busico A; Capone I; Picciani B; Valeri B; Pastorino U; Pelosi G
J Pathol Clin Res; 2017 Apr; 3(2):139-152. PubMed ID: 28451462
[TBL] [Abstract][Full Text] [Related]
47. An update on clinicopathological, immunohistochemical, and molecular profiles of colloid carcinoma of the lung.
Zenali MJ; Weissferdt A; Solis LM; Ali S; Tang X; Mehran RJ; Wistuba II; Moran CA; Kalhor N
Hum Pathol; 2015 Jun; 46(6):836-42. PubMed ID: 25776025
[TBL] [Abstract][Full Text] [Related]
48. MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy.
Garajová I; Funel N; Fiorentino M; Agostini V; Ferracin M; Negrini M; Frassineti GL; Gavelli G; Frampton AE; Biasco G; Giovannetti E
Clin Epigenetics; 2015; 7():129. PubMed ID: 26677401
[TBL] [Abstract][Full Text] [Related]
49. KRAS mutational analysis and immunohistochemical studies can help distinguish pancreatic metastases from primary lung adenocarcinomas.
Krasinskas AM; Chiosea SI; Pal T; Dacic S
Mod Pathol; 2014 Feb; 27(2):262-70. PubMed ID: 23887294
[TBL] [Abstract][Full Text] [Related]
50. Druggable oncogene fusions in invasive mucinous lung adenocarcinoma.
Nakaoku T; Tsuta K; Ichikawa H; Shiraishi K; Sakamoto H; Enari M; Furuta K; Shimada Y; Ogiwara H; Watanabe S; Nokihara H; Yasuda K; Hiramoto M; Nammo T; Ishigame T; Schetter AJ; Okayama H; Harris CC; Kim YH; Mishima M; Yokota J; Yoshida T; Kohno T
Clin Cancer Res; 2014 Jun; 20(12):3087-93. PubMed ID: 24727320
[TBL] [Abstract][Full Text] [Related]
51. Pulmonary Enteric Adenocarcinoma Harboring a BRAF G469V Mutation.
Shimizu D; Yamamoto H; Shien K; Taniguchi K; Miyoshi K; Namba K; Mesaki K; Sugimoto S; Soh J; Yamane M; Toyooka S
Acta Med Okayama; 2021 Dec; 75(6):759-762. PubMed ID: 34955547
[TBL] [Abstract][Full Text] [Related]
52. Mucinous Adenocarcinoma With Intrapulmonary Metastasis Harboring KRAS and GNAS Mutations Arising in Congenital Pulmonary Airway Malformation.
de Cordova XF; Wang H; Mehrad M; Eisenberg R; Johnson J; Wei Q; Borinstein S; Danko ME; Liang J
Am J Clin Pathol; 2021 Jul; 156(2):313-319. PubMed ID: 33609098
[TBL] [Abstract][Full Text] [Related]
53. [Correlation of clinicopathologic features and driver gene mutation in non-small cell lung cancer].
Chen LF; Chen XY; Yu XB
Zhonghua Bing Li Xue Za Zhi; 2016 Apr; 45(4):221-5. PubMed ID: 27033383
[TBL] [Abstract][Full Text] [Related]
54. Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations.
Ruiz-Cordero R; Ma J; Khanna A; Lyons G; Rinsurongkawong W; Bassett R; Guo M; Routbort MJ; Zhang J; Skoulidis F; Heymach J; Roarty EB; Tang Z; Medeiros LJ; Patel KP; Luthra R; Roy-Chowdhuri S
BMC Cancer; 2020 Jan; 20(1):83. PubMed ID: 32005111
[TBL] [Abstract][Full Text] [Related]
55. Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: An analysis of Iranian patients.
Fathi Z; Mousavi SAJ; Roudi R; Ghazi F
PLoS One; 2018; 13(7):e0200633. PubMed ID: 30048458
[TBL] [Abstract][Full Text] [Related]
56. The prognostic value of Kirsten rat sarcoma viral oncogene homolog mutations in resected lung adenocarcinoma differs according to clinical features.
Ma Z; Zhang Y; Deng C; Fu F; Deng L; Li Y; Chen H
J Thorac Cardiovasc Surg; 2022 Jan; 163(1):e73-e85. PubMed ID: 32739163
[TBL] [Abstract][Full Text] [Related]
57. [Relationship between EGFR and KRAS mutations and prognosis in Chinese patients with non-small cell lung cancer: a mutation analysis with real-time polymerase chain reaction using scorpion amplification refractory mutation system].
Gao J; Chen JQ; Zhang L; Liang ZY
Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):652-6. PubMed ID: 23302304
[TBL] [Abstract][Full Text] [Related]
58. Distribution and prognostic impact of EGFR and KRAS mutations according to histological subtype and tumor invasion status in pTis-3N0M0 lung adenocarcinoma.
Ito M; Miyata Y; Kushitani K; Ueda D; Takeshima Y; Okada M
BMC Cancer; 2023 Mar; 23(1):248. PubMed ID: 36918771
[TBL] [Abstract][Full Text] [Related]
59. Distinctive features of immunostaining and mutational load in primary pulmonary enteric adenocarcinoma: implications for differential diagnosis and immunotherapy.
Chen M; Liu P; Yan F; Xu S; Jiang Q; Pan J; He M; Shen P
J Transl Med; 2018 Mar; 16(1):81. PubMed ID: 29587865
[TBL] [Abstract][Full Text] [Related]
60. Pulmonary enteric adenocarcinoma.
Gong J; Fan Y; Lu H
Transl Oncol; 2021 Aug; 14(8):101123. PubMed ID: 34000642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
